Management of hyperlipidemia in children

Progress in Pediatric Cardiology

Volumn 12, Issue 2, 2001, Pages 205-213

  Starc, Thomas J ^a  

^a Columbia University ^*  (United States)

Author keywords

Atherosclerosis; Epidemiology; Hyperlipidemia

Indexed keywords

CHOLESTEROL; CHYLOMICRON; COLESTYRAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOTRETINOIN; LIPOPROTEIN; LIPOPROTEIN A; LONG CHAIN FATTY ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PRAVASTATIN; SIMVASTATIN; STEROID; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CHILD; CHOLESTEROL BLOOD LEVEL; DIET THERAPY; FAMILY HISTORY; FEMALE; HEALTH EDUCATION; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MALE; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SCREENING;

EID: 0035131642     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1058-9813(00)00075-8     Document Type: Article

References (64)

1. Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts
2. Comparison of cardiac findings at necropsy in octogenerians, nonagenarians and centenarians
3. The deadly quartet: upper-body obesity, glucose intolerance, hypertriyglyceridemia and hypertension
4. Disorders of lipoprotein metabolism and transport
5. Lipoprotein metabolism and atherogenesis: genetics and pathophysiology
6. Coronary disease among United States soldiers killed in action in Korea. Preliminary report
7. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study
8. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults
9. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: fate of early lesions in children (FELIC) study
10. A receptor mediated pathway for cholesterol homeostasis
11. HDL cholesterol predicts coronary heart disease mortality in older persons
12. Determinants of total and high density lipoprotein cholesterol in boys from Finland, The Netherlands, Italy, The Philippines and Ghana with special reference to diet
13. Adults aged 20 and older should have their cholesterol measured
14. Cholesterol screening guidelines consensus, evidence and common sense
15. Cholesterol screening guidelines Consensus, evidence and the departure from common sense
16. The case against childhood cholesterol screening
17. The case against 'the case against childhood cholesterol screening'
18. Cholesterol screening in children and adolescents
19. A rational approach to treating hypercholesterolemia in children. Weighing the risks and benefits
20. Use of cholesterol measurements in childhood for the prediction of adult hypercholesterolemia: the Muscatine study
21. Parental history of cardiovascular disease as an indication for screening for lipoprotein abnormalities in children
22. Family history fails to identify many children with severe hypercholesterolemia
23. Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states
24. Biochemical, clinical, epidemiological, genetic and pathologic data in the pediatric age group relevant to the cholesterol hypothesis
25. Pediatric implications of heterozygous familial hypercholesterolemia: screening and dietary treatment
26. Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood
27. Prevalence and expression of familial combined hyperlipidemia in childhood
28. Dietary therapy for children with hypercholesterolemia
29. An institutional approach to the dietary regulation of blood cholesterol in adolescent males
30. Normal growth in high-risk hyperlipidemic children and adolescents with dietary intervention
31. Growth of hypercholesterolemic children completing physician-initiated low-fat dietary intervention
32. A cholesterol-lowering diet does not produce adverse psychological effects in children: Three-year results from the dietary intervention study in children
33. Food sources, dietary behavior and the saturated fat intake of Latino children
34. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
35. Rational approach to pharmacologic reduction of cholesterol levels in children
36. Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24-36 months
37. Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia
38. Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial
39. Colestipol tablets in adolescents with familial hypercholesterolemia
40. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hyperchholesterolemia
41. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin
42. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia
43. Treatment of childhood hypercholesterolemia with HMG-CoA reductase inhibitors
44. National cholesterol education program recommendations for cholesterol testing in young adults. A science based approach
45. Lowering cholesterol levels: an ounce of prevention
46. Effects of nutritional counseling on lipoprotein levels in a pediatric clinic
47. Greater dietary intake of simple carbohydrate is associated with lower concentrations of high-density lipoprotein cholesterol in hypercholesterolemic children
48. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger
49. Family history of early cardiovascular disease in children with moderate to severe hypercholesterolemia: relation to lipoprotein(a) and LDL cholesterol levels
50. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes
51. Fibrinogen and risk of atherosclerotic heart disease
52. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women
53. Relations of plasma fibrinogen level in children to measures of obesity, the (G-4555 →A) mutation in the beta-fibrinogen promoter gene and family history of ischemic heart disease. The Columbia biomarkers study